NVIDIA
NVDA
Tesla
TSLA
Taiwan Semiconductor
TSM
4
Palantir
PLTR
5
Advanced Micro Devices
AMD
US Stock MarketDetailed Quotes
RBOT Vicarious Surgical
- 9.330
- -1.670-15.18%
Close Mar 3 16:00 ET
55.12MMarket Cap-0.90P/E (TTM)
11.204High9.300Low32.69KVolume11.000Open11.000Pre Close334.94KTurnover1.05%Turnover RatioLossP/E (Static)5.91MShares19.00052wk High0.95P/B29.03MFloat Cap4.27052wk Low--Dividend TTM3.11MShs Float473.565Historical High--Div YieldTTM17.31%Amplitude4.270Historical Low10.247Avg Price1Lot Size
Vicarious Surgical News
BTIG Maintains Vicarious Surgical(RBOT.US) With Hold Rating
BTIG Sticks to Its Hold Rating for Vicarious Surgical (RBOT)
Vicarious Surgical Is Maintained at Neutral by Piper Sandler
Vicarious Surgical Analyst Ratings
Promising Milestones and Financial Prudence Drive Buy Rating for Vicarious Surgical
TD Cowen Maintains Vicarious Surgical(RBOT.US) With Buy Rating, Raises Target Price to $13
BTIG Maintains Vicarious Surgical(RBOT.US) With Hold Rating
Morgan Stanley Maintains Vicarious Surgical(RBOT.US) With Hold Rating, Cuts Target Price to $6.5
Vicarious Surgical Analyst Ratings
TD Cowen Maintains Vicarious Surgical(RBOT.US) With Buy Rating, Maintains Target Price $10
Piper Sandler Maintains Vicarious Surgical(RBOT.US) With Hold Rating, Cuts Target Price to $12
Piper Sandler Sticks to Their Hold Rating for Vicarious Surgical (RBOT)
Vicarious Surgical's Progress and Upcoming Milestones Merit a Buy Rating
Vicarious Surgical Analyst Ratings
Morgan Stanley Cuts Price Target on Vicarious Surgical to $10 From $18, Keeps Equalweight Rating
Vicarious Surgical (RBOT) Gets a Hold From Piper Sandler
Buy Rating Affirmed: Vicarious Surgical's Advancements Poised to Disrupt Medical Robotics
A New Cause for Concern: Vicarious Surgical Inc. Adds a New Share Price & Shareholder Rights Risk
Vicarious Surgical Analyst Ratings
Analysts Offer Insights on Healthcare Companies: HCA Healthcare (HCA), Vicarious Surgical (RBOT) and 89bio (ETNB)